These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9834987)

  • 1. [New cytotoxics in the treatment of bronchial cancers].
    Quantin X; Godard P; Michel FB; Pujol JL
    Rev Mal Respir; 1998 Oct; 15(5):597-612. PubMed ID: 9834987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second-line chemotherapy for non-small cell lung cancer.
    Shepherd FA
    Expert Rev Anticancer Ther; 2003 Aug; 3(4):435-42. PubMed ID: 12934656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docetaxel: new indication. First-line treatment of non small-cell lung cancer: no advance.
    Prescrire Int; 2005 Feb; 14(75):16-8. PubMed ID: 15751170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of the unresectable non small cell lung carcinoma].
    Spásová I
    Cas Lek Cesk; 2005; 144(9):602-12; discussion 612-3. PubMed ID: 16193938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
    Hainsworth JD; Burris HA; Morrissey LH; Thomas M; Erland JB; Butts JA; Joseph G; Kalman L; Greco FA
    Cancer J; 2000; 6(3):151-6. PubMed ID: 10882330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of targeted therapy in non-small cell lung cancer: hype or hope?
    Langer CJ
    Expert Rev Anticancer Ther; 2003 Aug; 3(4):443-55. PubMed ID: 12934657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of oral topotecan in advanced non-small cell lung cancer.
    White SC; Cheeseman S; Thatcher N; Anderson H; Carrington B; Hearn S; Ross G; Ranson M
    Clin Cancer Res; 2000 Mar; 6(3):868-73. PubMed ID: 10741709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [First-line treatment of metastatic non-small cell lung cancers].
    Pérol M
    Rev Pneumol Clin; 2004 Nov; 60(5 Pt 2):3S51-6. PubMed ID: 15536354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on the role of topotecan in the treatment of non-small cell lung cancer.
    Stewart DJ
    Oncologist; 2004; 9 Suppl 6():43-52. PubMed ID: 15616149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in chemotherapy for small cell lung cancer: single-agent activity of newer agents.
    Argiris A; Murren JR
    Cancer J; 2001; 7(3):228-35. PubMed ID: 11419031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I and pharmacologic study of sequential topotecan-carboplatin-etoposide in patients with extensive stage small cell lung cancer.
    Miller AA; Al Omari A; Murry DJ; Case D
    Lung Cancer; 2006 Dec; 54(3):379-85. PubMed ID: 17049403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of hematopoietic growth factors in bronchial cancerology].
    Lemarié E; Milleron B
    Rev Mal Respir; 1995; 12(5):429-34. PubMed ID: 8560073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phase II clinical trials in patients with lung cancer].
    Shinkai T; Saijo N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31 Suppl():232-44. PubMed ID: 8007470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Topoisomerases: therapeutic value].
    Faure P; Madelaine I
    Ann Pharm Fr; 1996; 54(1):40-4. PubMed ID: 8702194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triplet combination chemotherapy and targeted therapy regimens.
    Bunn PA
    Oncology (Williston Park); 2001 Mar; 15(3 Suppl 6):26-32. PubMed ID: 11301845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Taxol (paclitaxel), first molecule of a new class of cytotoxic agents: taxanes].
    Chazard M; Pellae-Cosset B; Garet F; Soares JA; Lucidi B; Lavail Y; Lenaz L
    Bull Cancer; 1994 Mar; 81(3):173-81. PubMed ID: 7894125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New drugs in bronchial cancer].
    Delbaldo C; Faivre S; Monnerat C; Le Chevalier T
    Presse Med; 2002 May; 31(17):802-9. PubMed ID: 12148365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging toxicities in the treatment of non-small cell lung cancer: ocular disorders.
    Agustoni F; Platania M; Vitali M; Zilembo N; Haspinger E; Sinno V; Gallucci R; de Braud F; Garassino MC
    Cancer Treat Rev; 2014 Feb; 40(1):197-203. PubMed ID: 23850197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of elderly patients with non-small-cell lung cancer.
    Manegold C
    Oncology (Williston Park); 2001 Mar; 15(3 Suppl 6):46-51. PubMed ID: 11301849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Coagulation and bronchopulmonary cancers: from clinical aspects to biology].
    Brechot JM; Conard J; Samama M
    Rev Mal Respir; 1992; 9(4):375-84. PubMed ID: 1324514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.